Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002944 · ClinicalTrials.gov registry record · Phase 3
Combination Chemotherapy in Treating Children With Progressive Brain Tumors
A Phase 3 study, sponsored by Children's Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 428
- Enrollment target
NCT00002944 is a Phase 3 study that has completed, run by Children's Oncology Group. The registered enrollment target is 428 participants.
The verdict
NCT00002944, a Phase 3 study, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 428 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: This randomized phase III trial is studying two different combination chemotherapy regimens and comparing how well they work in treating children with low-grade astrocytomas or other residual tumors of the brain.
Interventions
- DRUG carboplatin
- DRUG vincristine sulfate
- DRUG lomustine
- DRUG procarbazine hydrochloride
- DRUG thioguanine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 428 participants |
| Start Date | 1997-04 |
| Est. Completion | 2012-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002944
The ClinicalTrials.gov registry entry for NCT00002944 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 428 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which carboplatin is the first listed.
NCT00002944 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002944 about?
NCT00002944 is a clinical study titled "Combination Chemotherapy in Treating Children With Progressive Brain Tumors". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: This randomized phase III trial is studying two different combination chemotherapy regimens and comparing how well...
What is the current status of trial NCT00002944?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 428 participants. The study started on 1997-04. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00002944?
The interventions under investigation include: carboplatin (DRUG), vincristine sulfate (DRUG), lomustine (DRUG), procarbazine hydrochloride (DRUG), thioguanine (DRUG).
Who is sponsoring clinical trial NCT00002944?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.